Australians Westernization and Lifestyle Diseases Boosts the Infusion Systems Market: Ken Research
All the chronic diseases in Australia are accompanied with long lasting conditions and persistent effects. Major chronic diseases in Australia are arthritis, asthma, back pain, cancer, cardiovascular disease, chronic obstructive pulmonary disease, diabetes and mental health conditions, osteoporosis, other musculoskeletal diseases, chronic kidney disease, oral diseases such as tooth decay and gum disease. Modernization over the last few years has led to increase in the chronic diseases which are a burden to the Australian population. In addition to the diseases, consumers are affected by the health-care costs and loss of productive work due to illness. Australian health system is focused on prevention and better management of chronic disease to improve health outcomes. According to the study “Australia Infusion Systems Market Outlook to 2023�, infusion pumps are medical devices used in healthcare facilities to inject fluids such as drugs, nutrients, and blood in a controlled systematic manner. Infusion systems are identified as the fundamental devices in the healthcare and life sciences industry. The increase in diseases and patients has led to the increase in the utility of the infusion pumps at hospitals, Ambulatory surgical centres (ASCs), and physician’s offices. The infusion pumps market has witnessed a steady growth due to the presence of numerous vendors in local and international markets. To improve their market positions, the global manufacturers of infusion pumps are investing in research and development, and technological innovations. The global leading players of infusion pumps are BD, Medtronic, Smiths Medical, Flowonix Medical, InfuSystem, Moog, Medovex, and Zimmer Biomet. Large hospitals in Australia are merged with medium and small hospitals to enhance the quality of medical treatment by increasing the number of skilled medical professionals. This merging improves capital investment, technology, and infrastructure of the small hospitals. These improvements in the hospitals will increase the number of patients, provides complicated treatments, and surgeries that need the infusion of drugs and fluids such as blood
and nutrients. Therefore, majority of the Australian hospitals would demand for infusion systems and will witness a steady growth in the infusion pumps category. The various infusion systems are injection port, IV cables, and syringes. The major drawbacks in the infusion systems are air embolism, infiltration, hematoma, and dose error, which will impact the growth of infusion systems. The infusion systems market is segmented into Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Infusion Disposable Set, Syringe Pumps and Volumetric Pumps. The leading players in Australian infusion systems market are Hospira Inc, Becton Dickinson and Co, Baxter International Inc and Medtronic plc. Majority of the infusion systems manufacturers in Australia depend on improved technologies, high-quality products, and brand image to raise their revenue. It was observed that modernization and increase in lifestyle diseases will drive the growth of the infusion systems market in Australia over the coming years. To know more, click on the link below: https://www.kenresearch.com/healthcare/medical-devices/australia-infusion-systemsmarket/135963-91.html
Related Reports: BRIC Infusion Systems Market Outlook to 2023 India Infusion Systems Market Outlook to 2023 Contact Us: Ken Research Ankur Gupta, Head Marketing & Communications sales@kenresearch.com 0124-4230204